MedTrace Logo

Influence of Cerebral Oedema in Intracerebral Haemorrhage

NCT04621357 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2026-04-22

No results posted yet for this study

Summary

In 2020, IntraCerebral Haemorraghe (ICH) remains the most devastating type of stroke. Besides stroke unit care, no specific treatment has been proven effective yet. Perihaematomal oedema (PHO) could be a promising therapeutic target. However, the mechanisms, the natural history as well as the clinical impact of this PHO remain unclear. The COPITCH study has been designed to answer these questions

Conditions

  • Stroke
  • Intra Cerebral Hemorrhage

Interventions

RADIATION

Brain MRI

Brain MRI will include differents sequences.

BIOLOGICAL

Biological biomarkers

Biological biomarkers will include a set of systemic inflammatory markers

Sponsors & Collaborators

  • Conseil Régional Hauts-de-France, France

    collaborator UNKNOWN

  • Fondation pour la recherche sur les AVC

    collaborator UNKNOWN

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Charlotte Cordonnier, MD,PhD · University Hospital, Lille

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2027-12-03
Completion
2027-12-03

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04621357 on ClinicalTrials.gov